Search Results - "Pozzato, P"

Persistent elevation of serum CA 19-9 with no evidence of malignant disease by Ventrucci, M, Pozzato, P, Cipolla, A, Uomo, G

“…Abstract Background Serum CA 19-9 is the mainstay marker for the diagnosis of biliopancreatic malignancies, though a persistent elevation can also be observed…”
Get full text

P.17.8 ENDOSCOPIC CLIPPING OF THE DIEULAFOY-LIKE LESION OF THE CAECUM PRESENTING WITH MASSIVE LOWER GASTROINTESTINAL BLEEDING by Pozzato, P, Ventrucci, M

Get full text

P.17.7 ARGON PLASMA COAGULATION FOR THE TREATMENT OF DIGESTIVE SYSTEM VASCULAR MALFORMATION AND RADIATION PROCTITIS by Pozzato, P, Ventrucci, M

Get full text

P.12.20 CLOSTRIDIUM DIFFICILE INFECTION SURVEY IN NHS HOSPITALS OF BOLOGNA by Pozzato, P, Ventracci, M, Farruggia, P, Panico, M, Descovich, C

Get full text

Capsule endoscopy for the diagnosis of midgut neuroendocrine carcinoma by Pozzato, P, Brancaccio, M, Tomassetti, P, Casetti, T, Ventrucci, M

Get full text

PA.115 VON HIPPEL-LINDAU DISEASE ASSOCIATED WITH MYASTENIA GRAVIS NOT RELATED TO THYMOMA by Pozzato, P, Sorrenti, G, Salvi, F, Ventrucci, M

Get full text

OC3.07.2 ASSOCIATION BETWEEN DYSPEPTIC SYMPTOMS AND ENDOSCOPIC FINDINGS IN THE GENERAL POPULATION: LOIANO-MONGHIDORO STUDY by Zagari, R.M, Forman, D, Law, G.R, Fuccio, L, Pozzato, P, Laterza, L, Bazzoli, F

Get full text

Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data by Bazzoli, F, De Luca, L, Pozzato, P, Zagari, RM, Fossi, S, Ricciardiello, L, Nicolini, G, Berretti, D, Roda, E

“…Many studies have attempted to prove a link between Helicobacter pylori infection and functional dyspepsia but the results have been conflicting. Several…”
Get full text

Measuring dyspepsia: a new severity index validated in Bologna by De Luca, L., Zagari, R.M., Pozzato, P., Fiorini, T., Ricciardiello, L., Martuzzi, C., Roda, E., Bazzoli, F., Veldhuyzen van Zanten, S.J.O.

“…Measurement of the severity of dyspepsia symptoms before and after treatment and determining what is a significant change is a major problem in designing…”
Get full text

Treatment of Helicobacter pylori infection. indications and regimens: an update by Bazzoli, F., Bianchi Porro, G., Maconi, G., Molteni, M., Pozzato, P., Zagari, R.M.

“…The management of Helicobacter pylori infection is still surrounded by controversy and uncertainties. Indications and correct application of current regimens…”
Get full text

Evaluation of short‐term low‐dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double‐blind, controlled study by BAZZOLI, F, ZAGARI, M, RODA, A, RODA, E, POZZATO, P, VAROLI, O, FOSSI, S, RICCIARDIELLO, L, ALAMPI, G, NICOLINI, G, SOTTILI, S, SIMONI, P

“…Background Studies demonstrating the efficacy of short‐term low‐dose triple therapies including omeprazole (O), clarithromycin (C) and a nitroimidazole…”
Get full text

Low‐dose lansoprazole and clarithromycin plus metronidazole vs. full‐dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection by Bazzoli, F., Zagari, R. M., Pozzato, P., Fossi, S., Ricciardiello, L., Nicolini, G., De Luca, L., Berretti, D., Alampi, G., Di Pietro, C., Morelli, P., Roda, E.

“…Aim: To compare, in a randomized controlled trial, the efficacy and tolerability of two 1‐week triple therapies for Helicobacter pylori eradication. Methods:…”
Get full text

Therapy of H. pylori infection by Bazzoli, F, Pozzato, P

“…A simple, safe and effective 1 week low dose triple therapy, omeprazole 20 mg u.i.d. clarithromycin 250 b.i.d. tinidazole 500 mg b.i.d. (OCT) was developed in…”
Get more information

Therapy and drug resistance in Helicobacter pylori infection by Bazzoli, F., Olivieri, L., De Luca, L., Pozzato, P., Lehours, P., Megraud, F.

Get full text

The Loiano‐Monghidoro population‐based study of Helicobacter pylori infection: prevalence by 13C‐urea breath test and associated factors by Bazzoli, F., Palli, D., Zagari, R. M., Festi, D., Pozzato, P., Nicolini, G., Masala, G., Fossi, S., Ricciardiello, L., Panuccio, D., Roda, E.

“…Objectives: As part of a cross‐sectional study on cholelithiasis, 1533 out of 1840 residents in Loiano/Monghidoro, a rural area in Northern Italy (792 men, 741…”
Get full text

Efficacy and safety of three 7‐day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate by RICCIARDIELLO, L, CANNIZZARO, O, TOSATTO, R, FOSSI, S, POZZATO, P, ZAGARI, M, BAZZOLI, F, RODA, E, D'ANGELO, A, EDERLE, A, GERACE, G, IAQUINTO, G, REINA, G, SCARPULLA, G, SPADACCINI, A, OLIVIERI, A

“…Background: This multicentre, randomized study was designed to assess the clinical efficacy, safety and tolerability of three novel 7‐day triple therapies…”
Get full text

Ranitidine bismuth citrate plus clarithromycin 7‐day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer by POZZATO, P, ZAGARI, M, TOSATTO, R, OLIVIERI, A, BAZZOLI, F, RODA, E, CARDELLI, A, CATALANO, F. A, GIGLIO, A, LAMI, F, PILOTTO, A, SCARPULLA, G, SPADACCINI, A, SUSI, D

“…Background: No clinical study has been performed to‐date to evaluate the efficacy of the dual therapy of ranitidine bismuth citrate (RBC) plus clarithromycin…”
Get full text

Helicobacter pylori: Optimum Diagnosis and Test of Cure by Bazzoli, F., Zagari, R.M., Pozzato, P., Fossi, S., Ricciardiello, L., De Luca, L., Nicolini, G., Berretti, D., Maltoni, S., Gorini, B., Martuzzi, C., Fuccio, L., Roda, E.

“…The fact that about 50% of the world's population is infected with Helicobacter (H.) pylori and the important role that this bacterium plays in public health…”
Get full text

Polyclinic Hospital of Milan in 1950: report to the Administration by POZZATO, P

Get more information

L'Ospedale Policlinico in 1949; relation to the Administrative Council of the Hospital Institutions of Milan by POZZATO, P

Get more information